Skip to main content
Premium Trial:

Request an Annual Quote

Dako Acquires IP from System Dynamics

NEW YORK (GenomeWeb News) – Agilent Technologies company Dako said recently that it signed an agreement to acquire the intellectual property rights behind connectivity software from System Dynamics.

SDI's development team will join Dako, bringing "new software development competencies to one of the world's leaders in cancer diagnostics," Dako said.

SDI has been a business partner and supplier to Dako for several years and the two worked together designing and developing DakoLink software for use in Dako's Autostainer and Artisan instruments, Dako added.

Terms of the deal were not disclosed.

"The acquisition of the intellectual property rights behind laboratory information system connectivity software is an important milestone for Dako in our efforts to further strengthen our position and capabilities in LIS connectivity," Jacob Thaysen corporate vice president of R&D for Dako, said in a statement. "Moreover, the SDI team will bring important competencies to Dako, ensuring our ability to continue the development of the DakoLink solution to the benefit of our customers in pathology laboratories around the world. "

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.